Bayer has issued a robust defence of Essure after the birth control implant was featured in The Bleeding Edge, a Netflix documentary about the medical devices industry.
Janssen has won US approval for its once-daily HIV pill Symtuza (D/C/F/TAF), which it hopes will improve patient adherence and resistance to treatment.
Siga Technologies has won US approval for Tpoxx, the first drug to be licensed to treat smallpox which, despite being eradicated in the 1980s, might be still used in a bioattack.